Finance

Lists
Why is 07X down 22.76%?
Dive Deeper
07X:FRA
Annovis Bio Inc
€0.75
-22.76%
(-0.22) 1D
Nov 5, 10:00:00 PM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 07X...
Open
€0.85
High
€0.85
Low
€0.75
Mkt. cap
28.55M
Avg. vol.
28.00
Volume
420.00
52-wk high
€4.61
52-wk low
€0.75
No. of employees
8
Open
€0.85
High
€0.85
Low
€0.75
Mkt. cap
28.55M
Avg. vol.
28.00
Volume
420.00
52-wk high
€4.61
52-wk low
€0.75
No. of employees
8
News stories
From web sources and news partners
About Annovis Bio Inc
CEOMaria-luisa Maccecchini
Employees8
Founded2008
HeadquartersMalvern, Pennsylvania, United States
SectorHealth Care
IndustryBiotechnology
Websiteannovisbio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6.29M
8.75M
16.72M
12.01M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.14M
955.15K
1.19M
2.37M
Operating expense
7.43M
9.71M
17.91M
14.38M
Total operating expenses
7.43M
9.71M
17.91M
14.38M
Operating income
-7.43M
-9.71M
-17.91M
-14.38M
Other non operating income
20.00K
-296.00K
268.00K
-603.34K
EBT including unusual items
-7.26M
-9.83M
-17.61M
-14.82M
EBT excluding unusual items
-7.26M
-9.83M
-17.51M
-14.82M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.26M
-9.83M
-17.61M
-14.82M
Net profit margin
-
-
-
-
Earnings per share
-0.37
-0.39
-0.63
-0.40
Interest and investment income
152.32K
167.74K
137.80K
160.23K
Interest expense
-
-
-
-
Net interest expenses
152.32K
167.74K
137.80K
160.23K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps